{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T04:38:41Z","timestamp":1785299921219,"version":"3.55.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2014,6,4]],"date-time":"2014-06-04T00:00:00Z","timestamp":1401840000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CEN Case Rep"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1007\/s13730-014-0124-3","type":"journal-article","created":{"date-parts":[[2014,6,3]],"date-time":"2014-06-03T02:27:11Z","timestamp":1401762431000},"page":"226-231","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Improvement in karyomegalic interstitial nephritis three years after ifosfamide and cisplatin therapy by corticosteroid"],"prefix":"10.1007","volume":"3","author":[{"given":"Tomokazu","family":"Matsuura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu","family":"Wakino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayumi","family":"Yoshifuji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshifumi","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirobumi","family":"Tokuyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akinori","family":"Hashiguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konosuke","family":"Konishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Iwasa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaaki","family":"Shoji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ako","family":"Hosono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Ohashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirokazu","family":"Chuman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Itoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,6,4]]},"reference":[{"key":"124_CR1","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1517\/14740330902808169","volume":"8","author":"L Hanly","year":"2009","unstructured":"Hanly L, Chen N, Rieder M, Koren G. Ifosfamide nephrotoxicity in children: a mechanistic base for pharmacological prevention. Expert Opin Drug Saf. 2009;8:155\u201368.","journal-title":"Expert Opin Drug Saf."},{"key":"124_CR2","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1002\/pbc.22364","volume":"54","author":"R Skinner","year":"2010","unstructured":"Skinner R, Parry A, Price L, Cole M, Craft AW, Pearson AD. Glomerular toxicity persists 10\u00a0years after ifosfamide treatment in childhood and is not predictable by age or dose. Pediatr Blood Cancer. 2010;54:983\u20139.","journal-title":"Pediatr Blood Cancer"},{"key":"124_CR3","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/(SICI)1096-911X(199609)27:3<149::AID-MPO3>3.0.CO;2-E","volume":"27","author":"VK Prasad","year":"1996","unstructured":"Prasad VK, Lewis IJ, Aparicio SR, Heney D, Hale JP, Bailey CC, Kinsey SE. Progressive glomerular toxicity of ifosfamide in children. Med Pediatr Oncol. 1996;27:149\u201355.","journal-title":"Med Pediatr Oncol"},{"key":"124_CR4","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1002\/pbc.21695","volume":"51","author":"DP Jones","year":"2008","unstructured":"Jones DP, Spunt SL, Green D, Springate JE. Renal late effects in patients treated for cancer in childhood: a report from the children\u2019s oncology group. Pediatr Blood Cancer. 2008;51:724\u201331.","journal-title":"Pediatr Blood Cancer"},{"key":"124_CR5","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/(SICI)1096-911X(199903)32:3<177::AID-MPO3>3.0.CO;2-H","volume":"32","author":"R Rossi","year":"1999","unstructured":"Rossi R, Pleyer J, Sch\u00e4fers P, Kuhn N, Kleta R, Deufel T, J\u00fcrgens H. Development of ifosfamide-induced nephrotoxicity: prospective follow-up in 75 patients. Med Pediatr Oncol. 1999;32:177\u201382.","journal-title":"Med Pediatr Oncol"},{"key":"124_CR6","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1054\/bjoc.2000.1214","volume":"82","author":"R Skinner","year":"2000","unstructured":"Skinner R, Cotterill SJ, Stevens MC. Risk factors for nephrotoxicity after ifosfamide treatment in children: a UKCCSG late effects group study. United Kingdom Children\u2019s Cancer Study Group. Br J Cancer. 2000;82:1636\u201345.","journal-title":"Br J Cancer"},{"key":"124_CR7","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1200\/JCO.1994.12.1.159","volume":"12","author":"R Rossi","year":"1994","unstructured":"Rossi R, G\u00f6dde A, Kleinebrand A, Riepenhausen M, Boos J, Ritter J, J\u00fcrgens H. Unilateral nephrectomy and cisplatin as risk factors of ifosfamide-induced nephrotoxicity: analysis of 120 patients. J Clin Oncol. 1994;12:159\u201365.","journal-title":"J Clin Oncol"},{"key":"124_CR8","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1002\/(SICI)1096-911X(199607)27:1<57::AID-MPO11>3.0.CO;2-2","volume":"27","author":"BJ Morland","year":"1996","unstructured":"Morland BJ, Mann JR, Milford DV, Raafat F, Stevens MC. Ifosfamide nephrotoxicity in children: histopathological features in two cases. Med Pediatr Oncol. 1996;27:57\u201361.","journal-title":"Med Pediatr Oncol"},{"key":"124_CR9","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1007\/s00467-011-1815-z","volume":"26","author":"T McCulloch","year":"2011","unstructured":"McCulloch T, Prayle A, Lunn A, Watson AR. Karyomegalic-like nephropathy, Ewing\u2019s sarcoma and ifosfamide therapy. Pediatr Nephrol. 2011;26:1163\u20136.","journal-title":"Pediatr Nephrol"},{"key":"124_CR10","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1159\/000013321","volume":"18","author":"MM Friedlaender","year":"1998","unstructured":"Friedlaender MM, Haviv YS, Rosenmann E, Peylan-Ramu N. End-stage renal interstitial fibrosis in an adult ten years after ifosfamide therapy. Am J Nephrol. 1998;18:131\u20133.","journal-title":"Am J Nephrol"},{"key":"124_CR11","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1002\/1097-0142(19950801)76:3<497::AID-CNCR2820760321>3.0.CO;2-C","volume":"76","author":"JS Berns","year":"1995","unstructured":"Berns JS, Haghighat A, Staddon A, Cohen RM, Schmidt R, Fisher S, Rudnick MR, Tomaszewski JE. Severe, irreversible renal failure after ifosfamide treatment. A clinicopathologic report of two patients. Cancer. 1995;76:497\u2013500.","journal-title":"Cancer"},{"key":"124_CR12","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/BF00292414","volume":"23","author":"PH Willemse","year":"1989","unstructured":"Willemse PH, de Jong PE, Elema JD, Mulder NH. Severe renal failure following high-dose ifosfamide and mesna. Cancer Chemother Pharmacol. 1989;23:329\u201330.","journal-title":"Cancer Chemother Pharmacol"},{"key":"124_CR13","doi-asserted-by":"crossref","first-page":"349","DOI":"10.5414\/CNP65349","volume":"65","author":"G Monga","year":"2006","unstructured":"Monga G, Banfi G, Salvadore M, Amatruda O, Bozzola C, Mazzucco G. Karyomegalic interstitial nephritis: report of 3 new cases and review of the literature. Clin Nephrol. 2006;65:349\u201355.","journal-title":"Clin Nephrol"},{"key":"124_CR14","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1093\/ndt\/17.11.1914","volume":"17","author":"S Bhandari","year":"2002","unstructured":"Bhandari S, Kalowski S, Collett P, Cooke BE, Kerr P, Newland R, Dowling J, Horvath J. Karyomegalic nephropathy: an uncommon cause of progressive renal failure. Nephrol Dial Transplant. 2002;17:1914\u201320.","journal-title":"Nephrol Dial Transplant"},{"key":"124_CR15","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/j.1742-7843.2007.00060.x","volume":"100","author":"A Ate\u015f\u015fah\u00edn","year":"2007","unstructured":"Ate\u015f\u015fah\u00edn A, Cer\u00edba\u015fi AO, Yuce A, Bulmus O, Cikim G. Role of ellagic acid against cisplatin-induced nephrotoxicity and oxidative stress in rats. Basic Clin Pharmacol Toxicol. 2007;100:121\u20136.","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"124_CR16","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/0272-6386(95)90005-5","volume":"25","author":"M Spoendlin","year":"1995","unstructured":"Spoendlin M, Moch H, Brunner F, Brunner W, Burger HR, Kiss D, Wegmann W, Dalquen P, Oberholzer M, Thiel G, Mihatsch MJ. Karyomegalic interstitial nephritis: further support for a distinct entity and evidence for a genetic defect. Am J Kidney Dis. 1995;25:242\u201352.","journal-title":"Am J Kidney Dis"},{"key":"124_CR17","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.taap.2007.03.025","volume":"222","author":"O Sehirli","year":"2007","unstructured":"Sehirli O, Sakarcan A, Velio\u011flu-O\u011f\u00fcn\u00e7 A, Cetinel S, Gedik N, Ye\u011fen BC, Sener G. Resveratrol improves ifosfamide-induced Fanconi syndrome in rats. Toxicol Appl Pharmacol. 2007;222:33\u201341.","journal-title":"Toxicol Appl Pharmacol"}],"container-title":["CEN Case Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13730-014-0124-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13730-014-0124-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13730-014-0124-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,11]],"date-time":"2019-08-11T02:45:23Z","timestamp":1565491523000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13730-014-0124-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6,4]]},"references-count":17,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["124"],"URL":"https:\/\/doi.org\/10.1007\/s13730-014-0124-3","relation":{},"ISSN":["2192-4449"],"issn-type":[{"value":"2192-4449","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,6,4]]}}}